Skip to content
★ Sign in to follow
RG
Total declarations
9
Companies
2
▲ Purchases (5 ops.)
€38k
▼ Sales (0 ops.)
—

Latest filing published 19 Aug 2015 for Corbus Pharmaceuticals Holdings, Inc., €8,530.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5
Positive at T+90
40%
Median T+90
-18.0%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Renu Gupta: trading record in brief

Renu Gupta has filed trades across 2 companies (mainly through SEC (Form 4)), most often in INSMED Inc and Corbus Pharmaceuticals Holdings, Inc. We count 9 filings; the first trade dates from 25 March 2011 and the latest from 18 August 2015.

On the market, this insider has only ever bought: 5 purchases, €38k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants and 2 option exercises. In 2015 alone, the filings show 2 purchases and no sales.

The median purchase comes to €8,530. After 5 purchases with a full 90-day history, the hit rate stands at 40% and the median 90-day move at -18.0%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 19 August 2015 with an open-market purchase (€8,530) in Corbus Pharmaceuticals Holdings, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Renu Gupta

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▲
    DirectorExecutivesCorbus Pharmaceuticals Holdings, Inc.
    9,450 USD0SEC
    5,000 shares@ US$1.89Common StockSEC:0001209191-15-066748:0
    Canonical exit: 15 Nov 2015 (T+90)
  • ▲
    DirectorExecutivesCorbus Pharmaceuticals Holdings, Inc.
    9,500 USD0SEC
    5,000 shares@ US$1.90Common stokcSEC:0001209191-15-066748:1
    Canonical exit: 16 Nov 2015 (T+90)
  • ▲
    DirectorExecutivesCorbus Pharmaceuticals Holdings, Inc.
    15,000 USD0SEC
    5,000 shares@ US$3.00Common StockSEC:0001209191-14-073303:0
    Canonical exit: 4 Mar 2015 (T+90)
  • ◇
    Executive Vice President & CMOExecutivesINSMED Inc
    0SEC
    27,900 sharesCommon StockSEC:0001573429-14-000034:0
  • ◆
    Executive Vice President & CMOExecutivesINSMED Inc
    212,225 USD0SEC
    10,393 shares@ US$20.42Common StockSEC:0001573429-14-000034:1
  • ◇
    EVP & Chief Medical OfficerExecutivesINSMED Inc
    0SEC
    27,900 sharesCommon StockSEC:0001104659-13-052949:0
  • ◆
    EVP & Chief Medical OfficerExecutivesINSMED Inc
    124,300 USD0SEC
    10,393 shares@ US$11.96Common StockSEC:0001104659-13-052949:1
  • ▲
    EVP & Chief Medical OfficerExecutivesINSMED Inc
    6,150 USD0SEC
    1,000 shares@ US$6.15Common StockSEC:0001140361-11-018920:0
    Canonical exit: 23 Jun 2011 (T+90)
  • ▲
    EVP & Chief Medical OfficerExecutivesINSMED Inc
    6,500 USD0SEC
    1,000 shares@ US$6.50Common StockSEC:0001140361-11-018920:1
    Canonical exit: 26 Jun 2011 (T+90)

9 of 9 declarations